Cited by 64Gestational Diabetes Research and ManagementOvarian function and disordersReproductive System and Pregnancy

Relationship between abnormal glucose tolerance test and history of previous recurrent miscarriages, and beneficial effect of metformin in these patients: a prospective clinical study

Open access
Zolghadri, Jaleh, Tavana, Zohreh, Kazerooni, Talie, Soveid, Mahmoud, Taghieh, Marzieh·2008·Fertility and Sterility

Abstract

Objective To determine the incidence of an abnormal glucose tolerance test in patients with recurrent spontaneous abortion and whether metformin would safely reduce the rate of first trimester spontaneous abortions in patients without polycystic ovary syndrome (PCOS) as well as with PCOS and an abnormal glucose tolerance test.Design Prospective control clinical trial.Setting Shiraz University-affiliated hospital.Patient(s) Patients with a history of recurrent spontaneous abortion and women with a history of normal full term pregnancy.Intervention(s) The incidence of abnormal carbohydrate metabolism was determined. Metformin and placebo were given to women with an abnormal glucose tolerance test and who had recurrent spontaneous abortions.Main outcome measure(s) Continuation of pregnancy beyond the first trimester in all groups and presence or absence of teratogenicity in the delivered baby after metformin therapy.Result(s) Twenty-nine of the patients in the group with recurrent spontaneous abortion were found to have an abnormal glucose tolerance test result compared with just four (5.4%) patients in the normal pregnancy group. The abortion rate was significantly reduced after metformin therapy in patients without PCOS in comparison to the placebo group (15% vs. 55%).Conclusion(s) This study indicates an important link between an abnormal glucose tolerance test and a history of recurrent abortion. It was also found that metformin therapy improves the chances of a successful pregnancy in patients with an abnormal glucose tolerance test.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.fertnstert.2007.06.079

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The prevalence of insulin resistance and abnormal glucose tolerance test appears to be increased in women with recurrent miscarriage compared with controls.

    “The prevalence of insulin resistance 91 and abnormal glucose tolerance test 92 appears to be increased in women with recurrent miscarriage compared with controls.”

    From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [92]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Catrington B, Sacks G, Regan L. Recurrent miscarriage: pathophysiol- ogy and outcome. Curr Opin Obstet Gynecol 2005;17:591-7.

Cited by

Sorted by citations

Authors
Zolghadri, J., Tavana, Z., Kazerooni, T., Soveid, M., & Taghieh, M.
Affiliations
Shiraz University of Medical Sciences (IR)
Corresponding author
Zolghadri, Jaleh
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
2008-09
Volume
90
Issue
3
Pages
727-730
ISSN
0015-0282 (ISSN-L)
OpenAlex
W2132180012
Cited by
64
References
21
Citations by year
2026: 3 · 2025: 5 · 2024: 4 · 2023: 6 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 5 · 2017: 3 · 2016: 6 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 3
FWCI
4.28
Type
journal article
Language
en
Open access
Locations
  • Fertility and Sterility (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Keywords
recurrent pregnancy loss, metformin, glucose tolerance test, impaired glucose tolerance, polycystic ovary syndrome, early pregnancy loss, teratogenicity, continuation of pregnancy, carbohydrate metabolism
MeSH terms
Abortion, Habitual, Adolescent, Adult, Female, Glucose Tolerance Test, Humans, Hyperinsulinism, Hypoglycemic Agents, Iran, Metformin, Pregnancy, Pregnancy Outcome, Risk Factors, Comorbidity, Prevalence, Treatment Outcome, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review